These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 20941625)

  • 1. Immunosuppressive mechanisms during viral infectious diseases.
    Sarikonda G; von Herrath MG
    Methods Mol Biol; 2011; 677():431-47. PubMed ID: 20941625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Travels along the viral-immunobiology highway.
    Oldstone MB
    Immunol Rev; 2002 Jul; 185():54-68. PubMed ID: 12190922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic depletion of natural killer cells controls persistent infection.
    Waggoner SN; Daniels KA; Welsh RM
    J Virol; 2014 Feb; 88(4):1953-60. PubMed ID: 24284324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innate and Adaptive Immune Regulation During Chronic Viral Infections.
    Zuniga EI; Macal M; Lewis GM; Harker JA
    Annu Rev Virol; 2015 Nov; 2(1):573-97. PubMed ID: 26958929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-10: achieving balance during persistent viral infection.
    Ng CT; Oldstone MB
    Curr Top Microbiol Immunol; 2014; 380():129-44. PubMed ID: 25004816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of IL-10 in regulating immunity to persistent viral infections.
    Wilson EB; Brooks DG
    Curr Top Microbiol Immunol; 2011; 350():39-65. PubMed ID: 20703965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decoding the complexity of type I interferon to treat persistent viral infections.
    Wilson EB; Brooks DG
    Trends Microbiol; 2013 Dec; 21(12):634-40. PubMed ID: 24216022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-10 and PD-L1 operate through distinct pathways to suppress T-cell activity during persistent viral infection.
    Brooks DG; Ha SJ; Elsaesser H; Sharpe AH; Freeman GJ; Oldstone MB
    Proc Natl Acad Sci U S A; 2008 Dec; 105(51):20428-33. PubMed ID: 19075244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Manipulating both the inhibitory and stimulatory immune system towards the success of therapeutic vaccination against chronic viral infections.
    Ha SJ; West EE; Araki K; Smith KA; Ahmed R
    Immunol Rev; 2008 Jun; 223():317-33. PubMed ID: 18613845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exhaustion and Inflation at Antipodes of T Cell Responses to Chronic Virus Infection.
    Cicin-Sain L; Arens R
    Trends Microbiol; 2018 Jun; 26(6):498-509. PubMed ID: 29249600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune Checkpoints in Viral Infections.
    Cai H; Liu G; Zhong J; Zheng K; Xiao H; Li C; Song X; Li Y; Xu C; Wu H; He Z; Zhu Q
    Viruses; 2020 Sep; 12(9):. PubMed ID: 32967229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Viral interactions with the host's immune system].
    Humlová Z
    Sb Lek; 2001; 102(3):329-39. PubMed ID: 12092118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Th17 Cells in Viral Infections-Friend or Foe?
    Paiva IA; Badolato-Corrêa J; Familiar-Macedo D; de-Oliveira-Pinto LM
    Cells; 2021 May; 10(5):. PubMed ID: 34064728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of antibody and complement in the control of viral infections.
    Cooper NR; Nemerow GR
    J Invest Dermatol; 1984 Jul; 83(1 Suppl):121s-127s. PubMed ID: 6376646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insights into type I interferon and the immunopathogenesis of persistent viral infections.
    Snell LM; Brooks DG
    Curr Opin Immunol; 2015 Jun; 34():91-8. PubMed ID: 25771184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune responses against persistent viral infections: possible avenues for immunotherapeutic interventions.
    Fuse S; Molloy MJ; Usherwood EJ
    Crit Rev Immunol; 2008; 28(2):159-83. PubMed ID: 18540829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral induced demyelination.
    Stohlman SA; Hinton DR
    Brain Pathol; 2001 Jan; 11(1):92-106. PubMed ID: 11145206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD8+ regulatory T cells in persistent human viral infections.
    Billerbeck E; Thimme R
    Hum Immunol; 2008 Nov; 69(11):771-5. PubMed ID: 18789990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterologous Immunity and Persistent Murine Cytomegalovirus Infection.
    Che JW; Daniels KA; Selin LK; Welsh RM
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27807227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective heterologous antiviral immunity and enhanced immunopathogenesis mediated by memory T cell populations.
    Selin LK; Varga SM; Wong IC; Welsh RM
    J Exp Med; 1998 Nov; 188(9):1705-15. PubMed ID: 9802982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.